Thyrocare Technologies informs about appointment of COO

18 Dec 2025 Evaluate

Thyrocare Technologies has informed that the Board of Directors (Board) of Thyrocare Technologies, upon the recommendation of the Nomination and Remuneration Committee (NRC), has approved the appointment of Dr. Ramesh Kinha as Chief Operating Officer of the Company, categorised as Senior Management Personnel, with effect from December 18, 2025. The aforesaid appointment was approved by the Board by way of a resolution passed by circulation on December 18, 2025 at 10:35 AM (IST). In compliance with Regulation 30 of the SEBI LODR Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, the requisite disclosure is enclosed as Annexure - 1. The aforesaid disclosures are also being made available on the website of the Company at https://investor.thyrocare.com/announcements/.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

436.80 8.90 (2.08%)
19-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7014.35
Max Healthcare Inst 1075.75
Narayana Hrudayalay 1907.90
Aster DM Healthcare 598.55
Global Health 1169.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×